文献速递细菌感染、耐药与抗菌药物

评估社区居住老年人延长抗生素疗程相关危害:一项使用工具变量分析的队列研究

Evaluating Harms Associated With Prolonged Antibiotic Duration of Therapy in Community-Dwelling Older Adults: A Cohort Study Using Instrumental Variable Analysis.
PubMed 文献 · Clin Infect Dis · 2025-01-01

该研究利用加拿大安大略省行政健康数据,纳入66-110岁接受阿莫西林、头孢氨苄和/或环丙沙星处方的门诊患者117682例,比较短疗程(3-7天)与长疗程(8-14天)的抗生素相关危害与安全性结局。工具变量分析显示,长疗程与短疗程在主要危害复合结局及次要安全性结局上均无显著差异。

要点

  • 长疗程与短疗程抗生素在主要危害复合结局上无显著差异。
  • 阿莫西林、头孢氨苄、环丙沙星三种药物的主要结局调整比值比95%CI均跨1。
  • 次要安全性结局(重复处方、就诊、死亡)在长疗程与短疗程间相似。

核心结论

  • 在社区居住老年人的工具变量分析中,与短疗程相比,长疗程抗生素未带来更多获益或危害。

研究设计与样本

  • 基于加拿大安大略省行政健康数据的基于人群的队列研究,纳入66-110岁接受阿莫西林、头孢氨苄和/或环丙沙星处方的门诊患者117682例。
  • 处方按疗程分为短疗程(3-7天)与长疗程(8-14天)。
  • 采用工具变量分析,工具变量为处方医生开具长疗程抗生素的比例。

主要发现

  • 主要危害复合结局(不良反应、艰难梭菌感染、抗生素耐药)调整比值比及95%CI:阿莫西林0.99(0.84-1.15);头孢氨苄1.11(0.90-1.38);环丙沙星0.94(0.74-1.20)。
  • 次要安全性复合结局(重复抗生素处方、就诊、死亡)比值比及95%CI:阿莫西林1.01(0.94-1.08);头孢氨苄1.06(0.97-1.17);环丙沙星0.99(0.85-1.15)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Shorter courses of antibiotic therapy are increasingly recommended to reduce antibiotic exposure. However, quantifying the real-world impact of duration of therapy is hindered by bias common in observational studies. We aimed to evaluate the harms and benefits of longer versus shorter duration of therapy in older adults. METHODS: This was a population-based cohort study using administrative health data from Ontario, Canada. We included outpatients aged 66-110 years who received a prescription for amoxicillin, cephalexin, and/or ciprofloxacin. Prescriptions were categorized as short (3-7 days) or long (8-14 days) duration. The primary outcome was a composite of antibiotic-related harms, including adverse reactions, Clostridioides difficile infection, and antibiotic resistance. The secondary outcome was a composite of safety measures including repeat antibiotic prescriptions, hospital visits, and mortality. To reduce risk of bias, we used an instrumental variable analysis where the instrument was prescriber proportion of antibiotics that were long duration. RESULTS: Among 117 682 eligible patients, there was no difference in the primary harms outcome for patients receiving longer versus shorter courses of antibiotics (adjusted odds ratio and 95% confidence interval [CI]): amoxicillin, 0.99 (.84-1.15); cephalexin, 1.11 (.90-1.38); ciprofloxacin, 0.94 (.74-1.20). Secondary safety outcomes were similar, with longer compared to shorter courses of antibiotic therapy (odds ratio and 95% CI): amoxicillin, 1.01 (.94-1.08); cephalexin, 1.06 (.97-1.17); ciprofloxacin, 0.99 (.85-1.15). CONCLUSIONS: In this instrumental variable analysis of community-dwelling older adults, longer antibiotic courses were not associated with an increased benefit or harm compared to shorter courses.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Langford BJ, Brown KA, Lau C, et al. Evaluating Harms Associated With Prolonged Antibiotic Duration of Therapy in Community-Dwelling Older Adults: A Cohort Study Using Instrumental Variable Analysis. Clin Infect Dis. 2025. PMID: 39786490. doi:10.1093/cid/ciae629

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。